82 Days
المصدر:
الصحة والعلوم الشرق الأوسط
المصدر: الصحة والعلوم الشرق الأوسط
82 Daysالصحة والعلوم الشرق الأوسط
المصدر: الصحة والعلوم الشرق الأوسط
82 Daysجاهز للتشغيل
جاهز للتشغيل
A study has shown that users of weight loss medications from the "GLP-1" class, such as "Ozempic" and "Wegovy," tend to reduce their level of physical activity after starting treatment, despite losing weight. The results emphasized the importance of regularly engaging in exercise to maintain muscle mass and health, as a decrease was observed in the average number of daily steps and overall physical activity among participants. The study also noted that weight loss does not automatically lead to increased physical activity, and necessary adjustments should include supportive movement programs and ongoing medical interventions.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading